Table 2.
Concept scores among participants.
| Characteristics | Self-efficacy: MUSEa | Self-efficacy: opioid safety | Perceived knowledge | Misuse harm | Behavioral intent | Safe storage | Safe disposal | Opioid knowledge | Narcan knowledge | Misuse behavior | |
| Overall | |||||||||||
|
|
N | 117 | 117 | 117 | 117 | 117 | 117 | 117 | 117 | 45 | 117 |
|
|
Mean (SD) | 0.28 (0.60) | 0.39 (0.71) | 0.93 (1.00) | 0.22 (0.94) | 0.25 (0.62) | 0.03 (0.20) | 0.08 (0.22) | 0.06 (0.16) | -0.04 (0.29) | 0.09 (0.28) |
|
|
Kruskal-Wallis P value | <.001 | <.001 | <.001 | .01 | <.001 | .09 | <.001 | <.001 | .6 | <.001 |
| Gender | |||||||||||
|
|
Female, mean (SD) | 0.35 (0.67) | 0.37 (0.70) | 1.14 (0.97) | 0.15 (0.72) | 0.33 (0.59) | 0.02 (0.22) | 0.12 (0.25) | 0.06 (0.16) | 0.00 (0.35) | 0.05 (0.28) |
|
|
Male, mean (SD) | 0.21 (0.51) | 0.39 (0.74) | 0.74 (1.00) | 0.27 (1.11) | 0.19 (0.65) | 0.04 (0.17) | 0.04 (0.17) | 0.05 (0.16) | -0.06 (0.25) | 0.14 (0.27) |
|
|
Kruskal-Wallis P value | .42 | .99 | .07 | .37 | .33 | .21 | .05 | .88 | .32 | .04 |
| Race (grouping 1) | |||||||||||
|
|
White or Caucasian, mean (SD) | 0.23 (0.41) | 0.30 (0.65) | 0.75 (0.91) | 0.20 (0.84) | 0.23 (0.66) | 0.02 (0.14) | 0.05 (0.18) | 0.03 (0.13) | -0.10 (0.30) | 0.10 (0.27) |
|
|
Black or African American, mean (SD) | 0.27 (0.75) | 0.20 (0.80) | 0.76 (0.90) | 0.15 (1.02) | 0.12 (0.65) | 0.02 (0.24) | 0.12 (0.26) | 0.07 (0.22) | 0.15 (0.24) | 0.01 (0.18) |
|
|
Hispanic or Latinx, mean (SD) | 0.25 (0.61) | 0.58 (0.82) | 1.27 (1.22) | 0.29 (1.08) | 0.40 (0.59) | 0.11 (0.29) | 0.10 (0.19) | 0.09 (0.15) | -0.11 (0.17) | 0.18 (0.34) |
|
|
Other or missing, mean (SD) | 0.54 (0.89) | 0.71 (0.45) | 1.37 (0.95) | 0.30 (1.00) | 0.30 (0.47) | -0.02 (0.07) | 0.10 (0.32) | 0.12 (0.18) | 0.17 (0.24) | 0.05 (0.33) |
|
|
Kruskal-Wallis P value | .76 | .04 | .02 | .78 | .72 | .36 | .58 | .23 | .04 | .38 |
| Race (grouping 2)b | |||||||||||
|
|
White or Caucasian, mean (SD) | 0.23 (0.41) | 0.30 (0.65) | 0.75 (0.91) | 0.20 (0.84) | 0.23 (0.66) | 0.02 (0.14) | 0.05 (0.18) | 0.03 (0.13) | -0.10 (0.30) | 0.10 (0.27) |
|
|
Non-White, mean (SD) | 0.33 (0.73) | 0.47 (0.76) | 1.10 (1.06) | 0.24 (1.03) | 0.27 (0.59) | 0.05 (0.24) | 0.11 (0.25) | 0.09 (0.18) | 0.06 (0.24) | 0.09 (0.29) |
|
|
Kruskal-Wallis P value | .73 | .21 | .03 | .42 | .63 | .73 | .23 | .26 | .12 | .80 |
| School | |||||||||||
|
|
High school, mean (SD) | 0.26 (0.56) | 0.34 (0.68) | 0.86 (0.94) | 0.19 (0.80) | 0.23 (0.68) | 0.03 (0.21) | 0.06 (0.19) | 0.04 (0.14) | -0.06 (0.30) | 0.12 (0.27) |
|
|
Middle school, mean (SD) | 0.31 (0.67) | 0.48 (0.78) | 1.07 (1.11) | 0.27 (1.17) | 0.30 (0.49) | 0.03 (0.17) | 0.13 (0.26) | 0.10 (0.19) | 0.03 (0.25) | 0.03 (0.28) |
|
|
Kruskal-Wallis P value | .42 | .21 | .23 | .51 | .45 | .77 | .06 | .34 | .39 | .15 |
| Grade | |||||||||||
|
|
Correlation coefficient | -0.17 | -0.14 | -0.17 | -0.08 | -0.09 | 0 | -0.18 | -0.23 | -0.1 | 0.12 |
|
|
95% CI | -0.34 to 0.02 | -0.31 to 0.05 | -0.34 to 0.02 | -0.25 to 0.11 | -0.26 to 0.10 | -0.18 to 0.18 | -0.35 to 0.00 | -0.40 to -0.05 | -0.38 to 0.20 | -0.06 to 0.30 |
|
|
Pearson's correlation P value | .07 | .15 | .07 | .41 | .35 | .98 | .06 | .01 | .52 | .18 |
| Age | |||||||||||
|
|
Correlation coefficient | -0.15 | -0.12 | -0.16 | -0.07 | -0.06 | 0 | -0.15 | -0.18 | -0.15 | 0.1 |
|
|
95% CI | -0.32 to 0.03 | -0.29 to 0.07 | -0.33 to 0.03 | -0.25 to 0.11 | -0.24 to 0.12 | -0.18 to 0.19 | -0.32 to 0.03 | -0.35 to 0.00 | -0.42 to 0.15 | -0.08 to 0.28 |
|
|
Pearson's correlation P value | .11 | .22 | .09 | .44 | .52 | .96 | .11 | .05 | .34 | .27 |
aMUSE: Medication Understanding and Use Self-Efficacy.
bRace grouping 2 examines participants who selected “White” as one category and every other option as “non-White.”